Natco Pharma Q1 Profit Soars 59% to Rs 668 Crore
Natco Pharma’s consolidated net profit surged 59% to Rs 668 crore for Q1 FY2024, up from Rs 420 crore a year earlier. Revenue climbed to Rs 1,363 crore from Rs 1,140 crore. The board declared an interim dividend of Rs 3 per share. Natco’s shares rose 3.48% to Rs 1,491.30 on the BSE. For investors, … Read more